Cargando…

eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain

Neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease are severe disorders with acute symptoms that gradually progress. In the course of developing disease-modifying treatments for neurodegenerative disorders there is a need to develop novel strategies to increase efficacy of drugs...

Descripción completa

Detalles Bibliográficos
Autor principal: Setty, Yaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467991/
https://www.ncbi.nlm.nih.gov/pubmed/30992468
http://dx.doi.org/10.1038/s41598-019-42261-3
_version_ 1783411343185936384
author Setty, Yaki
author_facet Setty, Yaki
author_sort Setty, Yaki
collection PubMed
description Neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease are severe disorders with acute symptoms that gradually progress. In the course of developing disease-modifying treatments for neurodegenerative disorders there is a need to develop novel strategies to increase efficacy of drugs and accelerate the development process. We developed a tool for simulating drug delivery in the brain by translating MRI data into an interactive 3D model. This tool, the eBrain, superimposes simulated drug diffusion and tissue uptake by inferring from the MRI data with a seamless display from any angle, magnification, or position. We discuss a representative implementation of eBrain that is inspired by clinical data in which insulin is intranasally administered to Alzheimer patients. Using extensive analysis of multiple eBrain simulations with varying parameters, we show the potential for eBrain to determine the optimal dosage to ensure drug delivery without overdosing the tissue. Specifically, we examined the efficacy of combined drug doses and potential compounds for tissue stimulation. Interestingly, our analysis uncovered that the drug efficacy is inferred from tissue intensity levels. Finally, we discuss the potential of eBrain and possible applications of eBrain to aid both inexperienced and experienced medical professionals as well as patients.
format Online
Article
Text
id pubmed-6467991
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64679912019-04-23 eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain Setty, Yaki Sci Rep Article Neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease are severe disorders with acute symptoms that gradually progress. In the course of developing disease-modifying treatments for neurodegenerative disorders there is a need to develop novel strategies to increase efficacy of drugs and accelerate the development process. We developed a tool for simulating drug delivery in the brain by translating MRI data into an interactive 3D model. This tool, the eBrain, superimposes simulated drug diffusion and tissue uptake by inferring from the MRI data with a seamless display from any angle, magnification, or position. We discuss a representative implementation of eBrain that is inspired by clinical data in which insulin is intranasally administered to Alzheimer patients. Using extensive analysis of multiple eBrain simulations with varying parameters, we show the potential for eBrain to determine the optimal dosage to ensure drug delivery without overdosing the tissue. Specifically, we examined the efficacy of combined drug doses and potential compounds for tissue stimulation. Interestingly, our analysis uncovered that the drug efficacy is inferred from tissue intensity levels. Finally, we discuss the potential of eBrain and possible applications of eBrain to aid both inexperienced and experienced medical professionals as well as patients. Nature Publishing Group UK 2019-04-16 /pmc/articles/PMC6467991/ /pubmed/30992468 http://dx.doi.org/10.1038/s41598-019-42261-3 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Setty, Yaki
eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain
title eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain
title_full eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain
title_fullStr eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain
title_full_unstemmed eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain
title_short eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain
title_sort ebrain: a three dimensional simulation tool to study drug delivery in the brain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467991/
https://www.ncbi.nlm.nih.gov/pubmed/30992468
http://dx.doi.org/10.1038/s41598-019-42261-3
work_keys_str_mv AT settyyaki ebrainathreedimensionalsimulationtooltostudydrugdeliveryinthebrain